CD46 (MCP) confers protection from lysis by xenogeneic antibodies.
Loveland
B E
BE
Austin Research Institute, Heidelberg, Victoria, Australia.
Johnstone
R W
RW
Russell
S M
SM
Thorley
B R
BR
McKenzie
I F
IF
D000818:Animals; D000910:Antibodies, Heterophile / Q000276:immunology*; D015703:Antigens, CD / Q000235:genetics / Q000276:immunology*; D016466:CHO Cells; D003165:Complement System Proteins / Q000276:immunology*; D006224:Cricetinae; D003602:Cytotoxicity, Immunologic; D004912:Erythrocytes / Q000276:immunology; D006801:Humans; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins / Q000235:genetics / Q000276:immunology*; D008954:Models, Biological; D011817:Rabbits; D013552:Swine; D014162:Transfection; D014183:Transplantation, Heterologous / Q000276:immunology*
D000910:Antibodies, Heterophile; D015703:Antigens, CD; C497857:CD46 protein, human; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins; D003165:Complement System Proteins